HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yangqiu Li Selected Research

T-Cell Antigen Receptors (T-Cell Receptor)

11/2022Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial.
1/2022Higher TIGIT+CD226- γδ T cells in Patients with Acute Myeloid Leukemia.
1/2019T cell receptor-engineered T cells for leukemia immunotherapy.
3/2017[Changes of TRGV genes and prognosis-related chemokine/receptor gene expressions in T cell lymphoma].
11/2016Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia.
9/2015Abnormalities in the T cell receptor Vδ repertoire and Foxp3 expression in refractory anemia with ringed sideroblasts.
7/2015Enhancement of the TCRζ expression, polyclonal expansion, and activation of t cells from patients with acute myeloid leukemia after IL-2, IL-7, and IL-12 induction.
3/2015Characteristics of TCRζ, ZAP-70, and FcɛRIγ gene expression in patients with T- and NK/T-cell lymphoma.
1/2015Evaluation of TCR repertoire diversity in patients after hematopoietic stem cell transplantation.
3/2014Distribution and clonality of the vα and vβ T-cell receptor repertoire of regulatory T cells in leukemia patients with and without graft versus host disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yangqiu Li Research Topics

Disease

46Neoplasms (Cancer)
11/2022 - 06/2000
33Leukemia
01/2022 - 03/2000
21BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2022 - 09/2000
19Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2022 - 09/2000
17Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2022 - 04/2010
16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2022 - 11/2010
15Hematologic Neoplasms (Hematological Malignancy)
09/2022 - 06/2000
9Acute Promyelocytic Leukemia
01/2021 - 04/2005
7Multiple Myeloma
03/2022 - 05/2011
6Lymphoma (Lymphomas)
04/2022 - 04/2010
6Myeloid Leukemia (Leukemia, Myelocytic)
04/2018 - 03/2000
5Graft vs Host Disease (Graft-Versus-Host Disease)
01/2019 - 03/2014
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 01/2017
4T-Cell Lymphoma (Lymphoma, T Cell)
07/2022 - 03/2015
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2014 - 05/2011
4B-Cell Lymphoma (Lymphoma, B Cell)
10/2014 - 01/2014
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2013 - 02/2010
3Stomach Neoplasms (Stomach Cancer)
06/2022 - 01/2020
3Pathologic Complete Response
01/2022 - 04/2009
3Carcinoma (Carcinomatosis)
01/2020 - 11/2014
3Carcinogenesis
08/2019 - 01/2015
3Melanoma (Melanoma, Malignant)
12/2018 - 01/2016
3Residual Neoplasm
06/2016 - 01/2013
2Retinoblastoma (Glioblastoma, Retinal)
06/2022 - 08/2019
2B-Cell Leukemia (Leukemia, B Cell)
01/2022 - 01/2021
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2016 - 08/2009
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2016 - 09/2000
2Blast Crisis (Blast Phase)
01/2014 - 09/2013
1Alcoholism (Alcohol Abuse)
10/2022
1T-Cell Leukemia (Leukemia, T Cell)
04/2022

Drug/Important Bio-Agent (IBA)

29T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2022 - 01/2002
17AntigensIBA
09/2022 - 01/2002
12Proteins (Proteins, Gene)FDA Link
06/2022 - 03/2000
10Chimeric Antigen ReceptorsIBA
09/2022 - 01/2017
8RNA (Ribonucleic Acid)IBA
07/2022 - 02/2015
8Small Interfering RNA (siRNA)IBA
08/2019 - 11/2010
7Immunoglobulins (Immunoglobulin)IBA
08/2022 - 10/2018
7Biomarkers (Surrogate Marker)IBA
07/2022 - 11/2016
7Imatinib Mesylate (Gleevec)FDA Link
09/2021 - 04/2010
7Biological ProductsIBA
03/2021 - 10/2008
6Messenger RNA (mRNA)IBA
04/2016 - 03/2000
5Tyrosine Kinase InhibitorsIBA
09/2021 - 09/2013
4CytokinesIBA
09/2022 - 06/2015
4Immune Checkpoint InhibitorsIBA
03/2021 - 01/2020
3Transcription Factors (Transcription Factor)IBA
12/2022 - 02/2015
3LigandsIBA
09/2022 - 09/2013
3CateninsIBA
11/2020 - 06/2017
3Long Noncoding RNAIBA
08/2019 - 09/2014
3Peptides (Polypeptides)IBA
01/2019 - 10/2005
3Oncogene Proteins (Oncogene Protein)IBA
01/2018 - 12/2012
33' Untranslated Regions (3' UTR)IBA
12/2016 - 12/2012
3VaccinesIBA
02/2013 - 04/2010
3SYBR Green IIBA
04/2012 - 11/2010
2Pharmaceutical PreparationsIBA
10/2022 - 12/2017
2Cyclin-Dependent Kinases (cdk Proteins)IBA
06/2022 - 08/2019
2Cyclin D1IBA
06/2022 - 08/2019
2Chemokine ReceptorsIBA
01/2022 - 03/2017
2Immune Checkpoint ProteinsIBA
01/2022 - 04/2020
2MesothelinIBA
01/2021 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2021 - 10/2018
2ChemokinesIBA
01/2021 - 03/2017
2AnthelminticsIBA
11/2020 - 04/2018
2pyrvinium (Vankin)FDA Link
11/2020 - 04/2018
2ChromatinIBA
01/2020 - 02/2015
2InterferonsIBA
01/2019 - 04/2010
2Interleukin-2 (IL2)IBA
01/2019 - 07/2015
2bcr-abl Fusion ProteinsIBA
01/2018 - 10/2017
2Insulin (Novolin)FDA Link
01/2017 - 01/2016
2Inosine Triphosphate (ITP)IBA
10/2016 - 08/2009
2NF-kappa B (NF-kB)IBA
11/2014 - 01/2014
2A-Form DNA (A-DNA)IBA
01/2013 - 04/2010
2gamma chain CD3 antigenIBA
05/2011 - 01/2011
1ParaffinIBA
11/2022
1Gefitinib (Iressa)FDA Link
11/2022
1ErbB Receptors (EGF Receptor)IBA
11/2022
1Disulfiram (Antabuse)FDA Link
10/2022
1Adenosine Triphosphatases (ATPase)IBA
10/2022
1Anaphase-Promoting Complex-CyclosomeIBA
10/2022
1Anaphase-Promoting Complex-Cyclosome Apc1 SubunitIBA
10/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2022
1UbiquitinIBA
10/2022
1LectinsIBA
08/2022
1physalin BIBA
06/2022
1Cyclin D3IBA
06/2022
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
06/2022
1CaspasesIBA
06/2022
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
06/2022
1Cyclin EIBA
06/2022
1Basic Helix-Loop-Helix Transcription FactorsIBA
04/2022
1Therapeutic UsesIBA
04/2022

Therapy/Procedure

23Immunotherapy
06/2022 - 06/2000
19Therapeutics
04/2022 - 04/2010
8Drug Therapy (Chemotherapy)
11/2022 - 10/2012
7Hematopoietic Stem Cell Transplantation
01/2019 - 04/2011
3Aftercare (After-Treatment)
03/2017 - 01/2013
2Cell- and Tissue-Based Therapy (Cell Therapy)
03/2022 - 10/2015
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2017 - 06/2000
2Ligation
01/2014 - 07/2013
2Stem Cell Transplantation
07/2013 - 08/2005
2Transplantation
04/2013 - 01/2009